Navigation Links
Data for EntreMed's ENMD-2076 to Be Presented at the Upcoming AACR-NCI-EORTC Conference
Date:11/3/2009

ROCKVILLE, Md., Nov. 3 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer today announced presentations for its Aurora A/angiogenic kinase inhibitor, ENMD-2076, at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics to be held November 15-19, 2009 in Boston, Massachusetts. Presentations are listed below.

(Logo: http://www.newscom.com/cgi-bin/prnh/20010620/ENMDLOGO )

  • Poster Session: Monday, November 16, 2009 - 12:30 p.m. - 2:30 p.m. Abstract No.: A106, "A Phase 1 study of ENMD-2076 in patients with relapsed or refractory acute myeloid leukemia (AML)," Halls C-D, 2nd floor.
  • Poster Session: Monday, November 16, 2009 - 12:30 p.m. - 2:30 p.m. Abstract No.: A156, "Mechanisms of resistance to Aurora kinase B inhibitors in leukemia: development and characterization of in vitro models," Halls C-D, 2nd floor.
  • Poster Session: Wednesday, November 18, 2009 - 12:30 p.m. - 2:30 p.m. Abstract No: C75, "A novel multi-targeted Aurora A and VEGFR2 kinase inhibitor, ENMD-2076, demonstrates synergistic antiproliferative and proapoptotic effects in combination with chemotherapy and trastuzumab in breast cancer cell lines," Halls C-D, 2nd floor.

About ENMD-2076

ENMD-2076 is an orally-active, Aurora A/angiogenic kinase inhibitor with a unique kinase selectivity profile and multiple mechanisms of action. Preclinical studies with ENMD-2076 demonstrate significant antitumor activity, including tumor regression, in multiple solid and hematological malignancies. ENMD-2076 has been shown to inhibit a distinct profile of angiogenic t
'/>"/>

SOURCE EntreMed
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. EntreMed Focuses on Development of ENMD-2076
2. Genomic Health Announces Multiple Studies on Oncotype DX(TM) Presented at 2007 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium
3. Nautica Malibu Triathlon Presented by Toyota Raises $718,000 for Childrens Hospital Los Angeles Pediatric Cancer Research
4. Success of Shape-Up Somerville Childhood Obesity Intervention to be Presented at the Friedman School Symposium at Tufts, October 29-31, 2007 - Boston
5. Success of Shape Up Somerville childhood obesity intervention to be presented
6. Survival data presented from phase II study of hormone-resistant prostate cancer patients
7. Special Olympics Special Spirit in China Award Of Excellence Presented to Dedicated Friends of Special Olympics and City of Shanghai
8. UltraShape(TM) Non-Invasive Fat Reduction and Body Contouring Clinical Study Results Presented at American Society for Dermatologic Surgery Annual Meeting
9. New Analyses of long-term LIALDA (mesalamine) data presented at ACG
10. Horizons AMI trial data to be presented at TCT 2007
11. AMIHOT II trial data presented at TCT

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2009)...v. 22 2009) -- Physician-scientists from Weill Cor...echanism that may prove to be a powerful target fo...of cancer that affects lymphocytes, or white blood...have been able to powerfully suppress tumor format...sing results have led to the design of a clinical ...
(Date:11/22/2009)... The holiday season is filled with get-...fun and joyous. It can also be stressful and tirin... stress, fatigue, and high fat foods -- factors th...hat,s why the National Foundation for Cancer Resea...can help ensure a happier, more healthful holiday ...
(Date:11/21/2009)...SHINGTON, Nov. 21 DNC C...fter the Senate voted to begin full debate of heal...tp://www.newscom.com/cgi-bin/prnh/20080519/DNCLOGO...c step on the road to enacting health insurance re...nators will now have an opportunity to debate the ...
(Date:11/21/2009)...ssociation Discusses Key Provisions of Legislation...m ,, ST. CHARLES, Ill., Nov. 21 /PRNewswire-US...ves passing the landmark Affordable Health Care fo...ey health reform legislation forward, Congress has...ealth care system. Today, AARP hosted an educatio...
(Date:11/21/2009)... HAPPYneuron,s most popular and addicti...e and iPod Touch. , Mount...ron,s most popular and addictive game, SplitWords,...lit Words is designed to help banish that ,tip of ... iPhone brain game challenges the brain by encour...
Breaking Medicine News(10 mins):Health News:New cancer target for non-Hodgkin's lymphoma 2Health News:Top 10 Food Tips for the Holidays from the National Foundation for Cancer Research 2Health News:Top 10 Food Tips for the Holidays from the National Foundation for Cancer Research 3Health News:Democratic National Committee Chairman Tim Kaine's Statement on the Senate's Vote to Proceed to Full Floor Debate of Health Insurance Reform Legislation 2Health News:AARP Hosts Rep. Bill Foster In Health Care Reform Forum 2Health News:HAPPYneuron releases iPhone Brain Game 2Health News:HAPPYneuron releases iPhone Brain Game 3
...regnancy are more likely to bear an underweight ch...thers because of genetic susceptibility.// The fin...es of low birth weight, though the researchers sai...regnant women with certain genotypes appeared to b...
...uggested that immunisation can protect against cot...still the leading cause of death in children over ...s about babies'sleeping position has dramatically ...ng to see if they had been immunised or not. They ...
...ve been drinking tap water contaminated with chemi... used to disinfect drinking water.// When it is ad...runoff from farms or lawns, however, it can form c...entified areas that may have increased health risk...
...eveloped by a research team from Southampton Unive... system to fight lymphoma,a cancer of the immune c...ally identified by the body's immune system, and s... the genetic material which identifies the cells a...
... often extremely painful to excrete, cost billions...ductivity. While the stones can sometimes be preve...ons and emptying the bladder frequently,// medicat... side effects. Men who develop kidney stones ...
...a has developed a micro capsule coated with silico...nsulin injection.This microchip works by absorbing...ulin- producing cells.Some diabetics have to injec...at Chicago Ms Desai, who presented her findings to...
Other Medicine News:
(Date:11/20/2009)...N.J., Nov. 20 BD (Becton...unced the completion of its acquisition of HandyLa... develops and manufactures molecular diagnostic as...BD and HandyLab announced an exclusive agreement f...s on the HandyLab Jaguar(TM) platform, the first f...
(Date:11/19/2009)...v. 19 In response to an ever-incre...llegal medicines, Operation Pangea II, involving 2...orld Health Organization,s International Medical P...highlight the dangers of buying medicines online. ...a series of arrests and the seizure of thousands o...
(Date:11/19/2009)...l., Nov. 19 The D e a... of its Most Admired Corporate Dealmakers for the ...t as its Most Admired Dealmaker in pharma/biotech ...ns and divestitures since January 2006. ,, Over... portfolio with a focus on high-growth, innovation...
Breaking Medicine Technology:BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3International Operation Combats Online Supply of Counterfeit and Illegal Medicines 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 3American Society for Clinical Pathology Joins the National Healthcare Career Network 51983 1American Society for Clinical Pathology Joins the National Healthcare Career Network 51983 2American Society for Clinical Pathology Joins the National Healthcare Career Network 51983 3QHR Client Hospitals Lauded for Consistently High Quality Standards Exceeding Patient Expectations 51981 1QHR Client Hospitals Lauded for Consistently High Quality Standards Exceeding Patient Expectations 51981 2QHR Client Hospitals Lauded for Consistently High Quality Standards Exceeding Patient Expectations 51981 3School of Health Management Honors 162 Graduating Students 51979 1School of Health Management Honors 162 Graduating Students 51979 2
...ix different studies will report on use of ImmuKno...of the International Society for Heart and Lung ...A, Md., April 9 Since it was initially cleared,as...ediated immunity (CMI),in immune-suppressed adult ...ns of the Cylex(TM) ImmuKnow(R) assay (in clinical...
...linsys continues expansion of team and drug develo...ough Therapeutically-aligned Program Strategists.,...l,Research, Inc.(R), a therapeutically focused glo...troduced its Therapeutically-aligned Program,Strat...tion and execution,of clinical trials. The TPS tea...
Other Medicine Technology:Independent Studies Report on Possible Roles for Cylex's Immune Cell Function Assay in Monitoring of Heart and Lung Transplant Recipients 2Independent Studies Report on Possible Roles for Cylex's Immune Cell Function Assay in Monitoring of Heart and Lung Transplant Recipients 3Clinsys(R) TPS Teams Provide Comprehensive Clinical Development Plans 2Clinsys(R) TPS Teams Provide Comprehensive Clinical Development Plans 3
Magic WALLSTENT® Stent System
Finnpipette Focus 12 channel, 1-10uL, micro
Finnpipette Digital Multichannel, 12 channel 0.5-10ul
Corning 12-Pette, 20-200 ul, 1-12 Channels
Medicine Products: